Table 3.
Number of outcomes reported in each pairwise combination of questionnaires.
| Comparison COVID-19–2020 Flu | Comparison COVID-19–2019 Flu | Comparison 2020 Flu–2019 Flu | ||||||
|---|---|---|---|---|---|---|---|---|
| Flu 2020 | Flu 2019 | Flu 2019 | ||||||
| No | Yes | No | Yes | No | Yes | |||
| Allergies | ||||||||
| COVID 19 No |
121 (94.5%) |
12 (26.1%) |
COVID-19 No |
90 (90.9%) |
12 (38.7%) |
Flu 2020 No |
93 (93.3%) |
8 (25.8%) |
| Yes | 7 (5.5%) | 34 (73.9%) | Yes | 9 (9.1%) | 19 (61.3%) | Yes | 6 (6.1%) | 23 (74.2%) |
| Chronic diseases | ||||||||
| COVID 19 No |
129 (88.4%) |
5 (17.2%) |
COVID-19 No |
97 (86.6%) |
3 (16.7%) |
Flu 2020 No |
107 (95.5%) |
3 (16.7%) |
| Yes | 17 (11.6%) | 24 (82.8%) | Yes | 15 (13.4%) | 15 (83.3%) | Yes | 5 (4.5%) | 15 (83.3%) |
| Medications/ supplements |
||||||||
| COVID 19 No |
92 (63.9%) |
3 (9.4%) |
COVID-19 No |
73 (65.8%) |
0 (0.0%) |
Flu 2020 No |
102 (91.9%) |
4 (21.1%) |
| Yes | 52 (36.1%) | 29 (90.6%) | Yes | 38 (34.2%) | 19 (100%) | Yes | 9 (8.1%) | 15 (78.9%) |